VALENCIA, Spain, March 19, 2024 (GLOBE NEWSWIRE) -- The European Academy of Allergy and Clinical Immunology (EAACI), with a membership of over 16,000 from 125 countries, annually orchestrates its congress to unveil the latest research and innovative advancements in allergy and clinical immunology. We are thrilled to extend a warm invitation to you for the upcoming EAACI Congress 2024, scheduled to take place in Valencia from May 31st to June 3rd, 2024. In a bid to provide you with an immersive experience, we will offer you a dedicated press area where you can schedule interviews with leading physicians and researchers in the field.
LOCATION: Our venue, Feria de Valencia, is a prestigious convention and exhibition centre known for its modernity and versatility. Moreover, the event will take place at the vibrant city of Valencia, which is celebrated for its harmonious coexistence of tradition and modernity.
PROGRAMME: The Scientific Programme will encompass the entire spectrum of Allergy and Clinical Immunology. Under the overarching theme of "Revolutionizing Patient Care Through the Power of Data Science" our congress promises to be an extraordinary intellectual journey. We are delighted to present a diverse and dynamic program featuring over 150 scientific sessions meticulously crafted to inform and inspire.
CONGRESS TOPICS:
Environmental Science: Join the conversation to understand how environmental issues have significantly increased allergic diseases such as bronchial asthma, allergic rhinoconjunctivitis, and atopic dermatitis in industrialized countries in recent years.
Food Allergy: A major public health issue with rising prevalence in metropolitan areas and a significant impact on the lives of patients with allergies. We will discuss about cutting-edge approaches to managing food allergies.
Innovations in Immunotherapy: Discover revolutionary developments in allergen immunotherapy, an area transforming the landscape of allergy treatment. Learn about the latest advances in the application of immunotherapy.
Pediatric Allergies: Explore the increasing incidence of allergies among children worldwide and the factors contributing to this phenomenon. Gain insights into global initiatives addressing pediatric allergies and collaborative efforts to enhance the well-being of young individuals affected by allergies.
KOLs of EAACI In this link, you'll find our dedicated committee, comprised of renowned doctors and scientists from various nationalities, available for interviews and reports.
The Honourable Soraya Martinez Ferrada, Minister of Tourism and Minister responsible for the Economic Development Agency of Canada for the Regions of Quebec, on behalf of the Honourable François-Philippe Champagne, Minister of Innovation, Science and...
CareDx, Inc. ? The Transplant Companytm ? a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers ? today...
Marcus Powlowski, Member of Parliament for Thunder Bay-Rainy River, on behalf of the Honourable Mark Holland, Minister of Health, will hold a news conference to announce funding to improve palliative care.
There will be a media availability...
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported the grant of...
Syndax Pharmaceuticals , a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on May 1, 2024 the Company granted inducement awards to purchase up to 100,600 shares of common stock to...
Today, U.S. Agency for International Development Administrator Samantha Power forged ahead in the fight against child malnutrition by announcing a $200 million investment in the procurement and distribution of Ready-to-Use Therapeutic Food (RUTF) ? a...